Pentasa 500mg Capsules

Manufacturer SHIRE Active Ingredient Mesalamine Long-Acting Capsules (Pentasa)(me SAL a meen) Pronunciation me SAL a meen
It is used to treat ulcerative colitis. It is used to help keep ulcerative colitis flares from coming back.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Anti-inflammatory agent
đŸ§Ŧ
Pharmacologic Class
Aminosalicylate
🤰
Pregnancy Category
Not available
✅
FDA Approved
Sep 1993
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Mesalamine is an anti-inflammatory medicine used to treat certain bowel conditions like ulcerative colitis. It works directly in your intestines to reduce inflammation and symptoms like diarrhea and abdominal pain.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, but be sure to take it with a full glass of water. Swallow the tablet whole - do not chew or crush it. If you have trouble swallowing the tablet whole, you can sprinkle the contents onto a small amount of applesauce or yogurt. Swallow the mixture immediately without chewing.

It's essential to continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better. This will help ensure that you receive the full benefits of the medication.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom. Some products may come with a desiccant packet in the container to protect the medication from moisture. If your container has a desiccant packet, be sure to keep it in the bottle. However, some brands may be stored without the desiccant for a short period. If you're unsure, consult with your doctor or pharmacist.

Keep all medications in a safe and secure location, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take capsules whole; do not chew, crush, or break them.
  • Can be taken with or without food.
  • Take consistently as prescribed, even if you feel better, to maintain remission.
  • Stay well-hydrated, especially if experiencing diarrhea.
  • Report any new or worsening symptoms to your doctor.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For Ulcerative Colitis (UC): 1000 mg (two 500 mg capsules) orally four times daily (4 g/day total) for up to 8 weeks. For Crohn's Disease (CD) (off-label): 500 mg to 1000 mg orally three to four times daily.
Dose Range: 2000 - 4000 mg

Condition-Specific Dosing:

Ulcerative Colitis (active, mild to moderate): 1000 mg (two 500 mg capsules) orally four times daily (4 g/day total) for up to 8 weeks.
Crohn's Disease (active, mild to moderate): 500 mg to 1000 mg orally three to four times daily (off-label, total daily dose typically 2-4 g/day).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For Ulcerative Colitis (active, mild to moderate): Dosing is weight-based, typically 50 mg/kg/day divided 2-3 times daily (max 4 g/day). Specific dosing for Pentasa capsules in children is not FDA-approved but used off-label.
Adolescent: For Ulcerative Colitis (active, mild to moderate): Dosing is weight-based, typically 50 mg/kg/day divided 2-3 times daily (max 4 g/day). Often adult dosing (4 g/day) is used for adolescents weighing >50 kg.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution. Monitor renal function.
Moderate: Use with caution. Monitor renal function closely. Consider dose reduction or extended dosing interval.
Severe: Contraindicated in patients with severe renal impairment (CrCl <30 mL/min) or renal failure.
Dialysis: Contraindicated. Mesalamine and its metabolites are substantially renally excreted. Accumulation may occur.

Hepatic Impairment:

Mild: Use with caution. Monitor liver function tests.
Moderate: Use with caution. Monitor liver function tests closely. No specific dose adjustments are provided, but close monitoring is warranted.
Severe: Use with caution. Contraindicated in patients with severe hepatic impairment due to potential for hepatotoxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Mesalamine (5-aminosalicylic acid or 5-ASA) is thought to exert its anti-inflammatory effects locally in the intestinal mucosa. While the exact mechanism is not fully elucidated, it is believed to modulate inflammatory responses by inhibiting cyclooxygenase and lipoxygenase pathways, thereby decreasing the production of prostaglandins and leukotrienes. It may also scavenge free radicals, inhibit cytokine production, and modulate immune cell function.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable and low systemic bioavailability (approximately 20-30% for Pentasa due to controlled release and first-pass metabolism). Designed for topical delivery to the entire GI tract.
Tmax: Plasma Tmax for 5-ASA is approximately 4-12 hours; for N-acetyl-5-ASA (metabolite) is 7-14 hours.
FoodEffect: Food may delay Tmax but does not significantly affect the extent of absorption (AUC).

Distribution:

Vd: Not extensively studied for systemic distribution due to local action. Limited systemic absorption.
ProteinBinding: 5-ASA: Approximately 43%; N-acetyl-5-ASA: Approximately 78%.
CnssPenetration: Limited

Elimination:

HalfLife: 5-ASA: Approximately 0.5-1.5 hours (systemic); N-Ac-5-ASA: Approximately 5-10 hours.
Clearance: Primarily renal excretion of both parent drug and metabolite.
ExcretionRoute: Renal (urine) and fecal (unabsorbed drug).
Unchanged: Less than 10% of absorbed 5-ASA is excreted unchanged in urine.
âąī¸

Pharmacodynamics

OnsetOfAction: Clinical improvement typically seen within 3-21 days, with full therapeutic effect often taking 3-8 weeks.
PeakEffect: Peak clinical response usually within 3-8 weeks of initiation.
DurationOfAction: Requires continuous dosing to maintain therapeutic effect.

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
+ Back pain, abdominal pain, or blood in the urine (may indicate a kidney stone)
Chest pain or pressure
Rapid or irregular heartbeat
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
New or worsening stomach pain or cramps, bloody stools, fever, headache, itching, rash, red or pink eyes, or general feeling of illness (may resemble ulcerative colitis symptoms)
Signs of liver problems, such as:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes (jaundice)
Signs of heart problems, including:
+ Shortness of breath
+ Sudden weight gain
+ Swelling in the arms or legs
Severe skin reactions, such as:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions, which may also affect internal organs
+ Symptoms include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other symptoms that concern you, contact your doctor:

Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Heartburn
Gas
Burping
Nose or throat irritation
Dizziness
Headache
Back pain
Cough

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe abdominal pain or cramping
  • Bloody diarrhea or rectal bleeding
  • Fever, chills, or sore throat (signs of infection or blood problems)
  • Unexplained bruising or bleeding
  • Yellowing of skin or eyes (jaundice), dark urine, or severe nausea/vomiting (signs of liver problems)
  • Decreased urination, swelling in legs/ankles, or unusual fatigue (signs of kidney problems)
  • Chest pain, shortness of breath, or rash (signs of hypersensitivity reaction)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Kidney disease or liver disease
+ Stomach or bowel ulcers
+ Narrowing of your stomach valve or other types of stomach blockages
+ Blockages in your urinary tract (consult with your healthcare provider if you have this condition)

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your existing health conditions and medications.

Remember, do not start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.

This medication may interfere with certain laboratory tests, so it is crucial to notify all your healthcare providers and laboratory personnel that you are taking this drug.

To stay hydrated, drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake.

While taking this medication, you may notice that your urine turns reddish-brown when it comes into contact with surfaces or water that have been treated with bleach, such as in a toilet. However, if you observe that your urine is reddish-brown before it comes into contact with any surfaces or water, please contact your doctor.

You may be more susceptible to sunburn while taking this medication. To minimize this risk, avoid exposure to the sun, sunlamps, and tanning beds. Use sunscreen and wear protective clothing and eyewear to safeguard your skin and eyes from the sun.

If you are 65 years or older, use this medication with caution, as you may be more prone to experiencing side effects.

Not all formulations of this medication are suitable for children. Before administering this drug to a child, consult with your doctor to determine the appropriate dosage and potential risks.

Do not give this medication to children and teenagers who have or are recovering from flu symptoms, chickenpox, or other viral infections, as this may increase the risk of Reye's syndrome, a rare but serious condition that can cause severe brain and liver damage.

If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks of this medication to you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Headache
  • Drowsiness
  • Confusion
  • Hyperventilation (rare, but possible metabolic acidosis)

What to Do:

Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is supportive and symptomatic. There is no specific antidote.

Drug Interactions

🔴

Major Interactions

  • Azathioprine
  • Mercaptopurine
  • Thiopurines (increased risk of myelosuppression)
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs) (increased risk of nephrotoxicity)
🟡

Moderate Interactions

  • Warfarin (potential for increased INR/bleeding)
  • Lactulose (may interfere with mesalamine release)
  • Drugs that alter gastric pH (e.g., antacids, PPIs - may affect dissolution of some mesalamine formulations, but less relevant for Pentasa's pH-independent release)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (serum creatinine, BUN, urinalysis)

Rationale: To establish baseline and identify pre-existing renal impairment, as mesalamine can cause nephrotoxicity.

Timing: Prior to initiation of therapy.

Liver function tests (ALT, AST, alkaline phosphatase, bilirubin)

Rationale: To establish baseline and identify pre-existing hepatic impairment, as mesalamine can cause hepatotoxicity.

Timing: Prior to initiation of therapy.

Complete Blood Count (CBC) with differential

Rationale: To establish baseline and monitor for blood dyscrasias (e.g., agranulocytosis, aplastic anemia) which are rare but serious adverse effects.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Renal function (serum creatinine, BUN, urinalysis)

Frequency: Periodically during therapy (e.g., at 3 months, then annually or as clinically indicated). More frequently in patients with pre-existing renal disease or on concomitant nephrotoxic drugs.

Target: Within normal limits or stable from baseline.

Action Threshold: Significant increase in creatinine, proteinuria, or other signs of renal dysfunction warrant investigation and potential discontinuation.

Liver function tests (ALT, AST, alkaline phosphatase, bilirubin)

Frequency: Periodically during therapy (e.g., at 3 months, then annually or as clinically indicated).

Target: Within normal limits or stable from baseline.

Action Threshold: Significant elevation (e.g., >3x ULN) warrants investigation and potential discontinuation.

Complete Blood Count (CBC) with differential

Frequency: Periodically during therapy (e.g., at 3 months, then annually or as clinically indicated). More frequently if patient develops signs of infection or bleeding.

Target: Within normal limits.

Action Threshold: Significant decrease in WBC, platelets, or hemoglobin warrants investigation and potential discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Worsening abdominal pain or cramping
  • Bloody diarrhea
  • Fever
  • Rash
  • Unexplained fatigue or weakness
  • Nausea or vomiting
  • Dark urine or yellowing of skin/eyes (jaundice)
  • Decreased urine output or swelling (signs of kidney problems)
  • Chest pain or shortness of breath (rare, but possible cardiac hypersensitivity)

Special Patient Groups

🤰

Pregnancy

Mesalamine is generally considered low risk during pregnancy. Studies in pregnant women have not shown an increased risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. However, use should be based on a careful risk-benefit assessment, as uncontrolled inflammatory bowel disease can pose greater risks to pregnancy outcomes.

Trimester-Specific Risks:

First Trimester: No increased risk of major birth defects observed.
Second Trimester: No specific risks identified.
Third Trimester: No specific risks identified. There have been rare reports of renal dysfunction in neonates exposed to mesalamine in utero, particularly with high doses or in mothers with pre-existing renal impairment. Monitor neonatal renal function if exposed.
🤱

Lactation

Mesalamine and its metabolite are excreted in breast milk in small amounts. While generally considered compatible with breastfeeding, caution is advised. Monitor breastfed infants for signs of diarrhea.

Infant Risk: Low. Rare reports of diarrhea in breastfed infants. If diarrhea develops, discontinue breastfeeding or the drug.
đŸ‘ļ

Pediatric Use

Pentasa capsules are not FDA-approved for pediatric use, but mesalamine is commonly used off-label in children for ulcerative colitis. Dosing is typically weight-based. Close monitoring for adverse effects, especially renal and hepatic function, is crucial.

👴

Geriatric Use

Use with caution in elderly patients, as they are more likely to have decreased renal function. Monitor renal function closely. Start at the lower end of the dosing range.

Clinical Information

💎

Clinical Pearls

  • Pentasa capsules contain microgranules that are designed to release mesalamine throughout the entire GI tract (pH-independent release), making it suitable for both ulcerative colitis and Crohn's disease.
  • Patients should swallow the capsules whole. If swallowing is difficult, the capsules can be opened and the contents sprinkled on applesauce or yogurt and consumed immediately.
  • Adherence is crucial for maintaining remission in IBD. Emphasize the importance of consistent daily dosing.
  • Mesalamine can cause an acute intolerance syndrome, which mimics a flare of IBD (cramping, abdominal pain, bloody diarrhea, fever, headache, rash). If this occurs, discontinue the drug immediately.
  • Rare but serious adverse effects include nephrotoxicity, hepatotoxicity, and blood dyscrasias. Regular monitoring of renal, hepatic, and hematologic parameters is important.
🔄

Alternative Therapies

  • Other oral mesalamine formulations (e.g., Lialda, Apriso, Asacol HD, Delzicol - differ in release mechanism and site of action)
  • Rectal mesalamine (suppositories, enemas) for distal colitis
  • Corticosteroids (e.g., prednisone, budesonide) for induction of remission
  • Immunomodulators (e.g., azathioprine, mercaptopurine, methotrexate)
  • Biologic agents (e.g., infliximab, adalimumab, vedolizumab, ustekinumab)
  • JAK inhibitors (e.g., tofacitinib)
💰

Cost & Coverage

Average Cost: Varies widely, typically $300-$800+ per 120 capsules (500mg)
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (Brand), Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.